Sagimet Biosciences (SGMT) Insider Trading & Ownership $3.14 -0.14 (-4.27%) (As of 09/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Sagimet Biosciences (NASDAQ:SGMT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage17.60%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$65,153.50Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$178,223.55 Get SGMT Insider Trade Alerts Want to know when executives and insiders are buying or selling Sagimet Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SGMT Insider Buying and Selling by Quarter Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Sagimet Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/23/2024George KembleChairmanSell23,625$3.17$74,891.25 7/19/2024Eduardo Bruno MartinsInsiderSell8,357$3.10$25,906.70 7/19/2024Elizabeth RozekGeneral CounselSell10,914$3.10$33,833.40 7/19/2024George KembleChairmanSell14,062$3.10$43,592.20 3/26/2024David HappelCEOBuy12,100$5.27$63,767.00 11/16/2023David HappelCEOBuy590$2.35$1,386.50 (Data available from 1/1/2013 forward) SGMT Insider Trading Activity - Frequently Asked Questions Who is on Sagimet Biosciences's Insider Roster? The list of insiders at Sagimet Biosciences includes Beth C Seidenberg, David Happel, Eduardo Bruno Martins, Elizabeth Rozek, Enterprise Associates 13 L New, and George Kemble. Learn more on insiders at SGMT. What percentage of Sagimet Biosciences stock is owned by insiders? 17.60% of Sagimet Biosciences stock is owned by insiders. Learn more on SGMT's insider holdings. Which Sagimet Biosciences insiders have been buying company stock? The following insiders have purchased SGMT shares in the last 24 months: Beth C Seidenberg ($750,000.00), David Happel ($65,153.50), and Enterprise Associates 13 L New ($480,000.00). How much insider buying is happening at Sagimet Biosciences? Insiders have purchased a total of 89,565 SGMT shares in the last 24 months for a total of $1,295,153.50 bought. Which Sagimet Biosciences insiders have been selling company stock? The following insiders have sold SGMT shares in the last 24 months: Eduardo Bruno Martins ($25,906.70), Elizabeth Rozek ($33,833.40), and George Kemble ($118,483.45). How much insider selling is happening at Sagimet Biosciences? Insiders have sold a total of 56,958 Sagimet Biosciences shares in the last 24 months for a total of $178,223.55 sold. More Insider Trading Tools from MarketBeat Related Companies: AQST Insider Ownership CYRX Insider Ownership CGC Insider Ownership GLTO Insider Ownership NLTX Insider Ownership FHTX Insider Ownership CRMD Insider Ownership KRRO Insider Ownership GTHX Insider Ownership STRO Insider Ownership Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: This Is the Top Large-Cap Stock Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?Top 3 Small-Cap Stocks Insiders Are Buying Right Now3 Small Cap Stocks That Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued Stock This page (NASDAQ:SGMT) was last updated on 9/20/2024 by MarketBeat.com Staff From Our PartnersHow the US Will Win the Great Lithium RaceChina spent $60B+ on lithium infrastructure in the past decade. It possesses 7.9% of the world’s supply, but i...DealMaker | SponsoredThe Perfect Storm for an EV RevoltWith constant talk about Artifical Intelligence, inflation, and the upcoming election clogging the airwaves......Eagle Publishing | SponsoredThe election trade you can't losePolitics is an unpredictable game. But no matter what happens in the next few months... There's one thin...Investors Alley | SponsoredAre You Ready for a Small-Cap Rally?Jeff Bezos has just made a bold move into Quantum Computing as a Service (QaaS), a technology set to disrupt i...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMust-Know for Trading OptionsOptions are becoming increasingly popular among investors – with demand hitting record highs for 3 years in a ...Unstoppable Prosperity | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sagimet Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sagimet Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
